melanoma

Does This Drug Offer Exelixis Inc. Investors Hope for the Future?
Motley Fool
Fri, 01/2/15 - 08:25 am
Exelixis
Cobimetinib
melanoma
Early Opdivo OK gives BMS more time to erase Keytruda's lead
Medical Marketing and Media
Wed, 12/24/14 - 09:29 am
Opdivo
Bristol-Myers Squibb
Keytruda
melanoma
FDA approves Bristol-Myer's skin cancer drug
Yahoo/Reuters
Mon, 12/22/14 - 04:44 pm
FDA
Opdivo
Bristol-Myers Squibb
melanoma
Novogen Shares Skyrocket 120% Following Melanoma Drug News
Yahoo/Benzinga
Tue, 12/16/14 - 11:38 am
Novogen
melanoma
TRXE-009
Roche submits NDA for skin cancer med
Seeking Alpha
Mon, 12/15/14 - 11:09 am
Roche
Cobimetinib
Zelboraf
melanoma
FDA
Celldex's Glembatumumab Vedotin in Phase II for Melanoma
Yahoo/Zacks
Sat, 12/6/14 - 10:57 am
Celldex Therapeutics
glembatumumab vedotin
melanoma
Five Prime gets $30M upfront from Bristol-Myers and will study combination cancer treatment
Yahoo/AP
Mon, 11/24/14 - 06:03 pm
Five Prime
Bristol-Myers Squibb
Opdivo
FPA008
melanoma
Melanoma Treatment Battle Between Roche And GSK Heats Up
Bidness Etc.
Tue, 09/30/14 - 06:27 pm
melanoma
Roche
GSK
Zelboraf
Tafinlar
Bristol immune drug shows strong effect in melanoma study
Yahoo/Reuters
Mon, 09/29/14 - 07:46 am
Bristol-Myers Squibb
Opdivo
melanoma
GSK melanoma pill backed by UK cost watchdog with price cut
Yahoo/Reuters
Thu, 09/18/14 - 08:59 am
GSK
UK
melanoma
Tafinlar
Merck's Mantra On Focus Precludes An Inversion Strategy
Forbes
Mon, 09/15/14 - 08:47 am
Merck
tax inversions
Keytruda
melanoma
Merck's Anti-PD-1 Drug Keytruda First to be Launched in US
Yahoo/Zacks
Sat, 09/6/14 - 09:11 am
Keytruda
Merck
melanoma
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Fri, 09/5/14 - 10:04 am
Merck
melanoma
Keytruda
Bristol-Myers Squibb
Opdivo
FDA OKs Merck melanoma drug, 1st in new class of cancer drugs with big advantages over chemo
Yahoo/AP
Thu, 09/4/14 - 06:11 pm
Merck
FDA
melanoma
Keytruda
Amgen submits melanoma-fighter T-Vec to EMA on the heels of its FDA filing
Fierce Vaccines
Tue, 09/2/14 - 06:54 pm
T-Vex
Amgen
melanoma
FDA
Europe
vaccines
Merck’s Melanoma Drug To Get FDA Approval Earlier Than Expected
Bidness Etc.
Tue, 08/26/14 - 09:47 am
Merck
melanoma
FDA
The real 'exclusive' at Merck: R&D is back in the saddle, baby
Fierce Biotech
Mon, 08/25/14 - 08:48 am
Merck
R&D
melanoma
Pembrolizumab
GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Sat, 07/19/14 - 09:20 am
trametinib
GSK
vemurafenib
dabrafenib
melanoma
Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma
First Word Pharma
Thu, 07/17/14 - 10:12 am
GSK
Mekinist
Tafinlar
Zelboraf
melanoma
Roche, Exelixis Skin Cancer Drug Delays Tumor Progression
TheStreet.com
Mon, 07/14/14 - 10:32 am
Roche
Exelixis
melanoma
Cobimetinib
Zelboraf

Pages